-

AVI Seeks Removal of Third Point Director at TPIL

LONDON--(BUSINESS WIRE)--Asset Value Investors (AVI), which manages AVI Global Trust (AGT.LN), confirms that it and three other shareholders collectively owning over 18 per cent. of the Ordinary Shares requisitioned the TPIL Board on 2 November 2021 to convene an extraordinary general meeting (EGM) of TPIL at which Shareholders will be asked to vote on a resolution to remove Joshua L Targoff, the representative of Third Point LLC on the Board, as a director of TPIL. We have chosen to disclose this today given the Board’s failure to inform the market of their receipt of this requisition.

We intend to publish an open letter to Shareholders providing full background to this requisition as soon as a date has been set for the EGM.

Contacts

Tom Treanor
Head of Research/Executive Director
Tom.treanor@assetvalueinvestors.com

AVI Global Trust plc


Release Versions

Contacts

Tom Treanor
Head of Research/Executive Director
Tom.treanor@assetvalueinvestors.com

Social Media Profiles
More News From AVI Global Trust plc

AVI Calls for Changes at Gerresheimer

LONDON--(BUSINESS WIRE)--Asset Value Investors (“AVI”) has sent an open letter to the Supervisory Board of Gerresheimer AG (“Gerresheimer”) calling for it to make changes to its financial leadership. You can find the published letter here. AVI invested in Gerresheimer in 2024 and manages a 3.5% stake on behalf of institutional clients. Gerresheimer holds a valuable position in the Containment Solutions & Delivery Systems industry, with high barriers to entry and attractive long-term growth...

AVI Urges Wacom To Make Governance Changes

LONDON--(BUSINESS WIRE)--Asset Value Investors Limited (“AVI”) launches a campaign calling for Wacom Corporation (“Wacom”) to be more conscious of the capital market, and announces that AVI has submitted shareholder proposals ahead of Wacom’s upcoming AGM in June. AVI has published a detailed presentation on a dedicated website. AVI invested in Wacom in August 2021 and has sought to engage in dialogue with the company as the largest shareholder, sending letters and presentations with the aim of...

Asset Value Investors Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage With Shareholders More Constructively

LONDON--(BUSINESS WIRE)--Asset Value Investors Limited (‘AVI’) launches a campaign calling for Rohto Pharmaceutical (‘Rohto’) to focus on its core businesses rather than allocating resources to the unsuccessful regenerative medicine business, and to engage with shareholders more constructively to comply with the Tokyo Stock Exchange’s (‘TSE’) request for management that is conscious of the cost of capital and stock price. A detailed presentation can be found here. Since AVI started investing in...
Back to Newsroom